PHARMACOLOGY AND THE NURSING
PROCESS 9TH EDITION CHAPTER 1-58 BY
LINDA LANE LILLEY, SHELLY
RAINFORTH COLLINS, JULIE S. SNYDER||
LATEST 2025 WITH VERIFIED
SOLUTIONS|| ASSURED PASS!!!
,1|P a g e
PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
CHAPTER 1-58 BY LINDA LANE LILLEY, SHELLY RAINFORTH COLLINS,
JULIE S. SNYDER|| LATEST 2025 WITH VERIFIED SOLUTIONS|| ASSURED
PASS!!!
Chapter n01: nThe nNursing nProcess nand nDrug nTherapy
n MULTIPLE nCHOICE
1. During nan nintravenous n(IV) ninfusion nof namphotericin nB, na npatient
ndevelops ntingling nand nnumbnessin nhis ntoes nand nfingers. nWhat nwill nthe nnurse
ndo nfirst?
a. Discontinue nthe ninfusion nimmediately.
b. Reduce nthe ninfusion nrate ngradually nuntil nthe nadverse neffects nsubside.
c. Administer nthe nmedication nby nrapid nIV ninfusion nto nreduce nthese neffects.
d. Nothing; nthese nare nexpected nside neffects nof nthis nmedication.
- ANSWER: nA
Once nthe nintravenous ninfusion nof namphotericin nB nhas nbegun, nvital nsigns nmust nbe
nmonitored nfrequently nto nassess nfor nadverse nreactions nsuch nas ncardiac
ndysrhythmias, nvisual ndisturbances, nparesthesias n(numbness nor ntingling nof nthe
nhands nor nfeet), nrespiratory ndifficulty, npain, nfever, nchills,and nnausea. nIf nthese
nadverse neffects nor na nsevere nreaction noccur, nthe ninfusion nmust nbe
ndiscontinued(while nthe npatient nis nclosely nmonitored) nand nthe nprescriber
ncontacted. nThe nother noptions nare nincorrect.
DIF: nCOGNITIVE nLEVEL: nApplying
(Application)TOP: nNURSING nPROCESS: nImplementation
MSC: nNCLEX: nPhysiological nIntegrity: nPharmacological nand nParenteral nTherapies
,2 n| nP n a n g n e
The nnurse nis nwriting na nnursing ndiagnosis nfor na nplan nof ncare nfor na npatient nwho
nhas nbeen nnewlydiagnosed nwith ntype n2 ndiabetes. nWhich nstatement nreflects nthe
ncorrect nformat nfor na nnursing ndiagnosis?
a. Anxiety
b. Anxiety nrelated nto nnew ndrug ntherapy
c. Anxiety nrelated nto nanxious nfeelings nabout ndrug ntherapy, nas nevidenced
nby nstatements
such nas n“I’m nupset nabout nhaving nto ntest nmy nblood nsugars.”
d. Anxiety nrelated nto nnew ndrug ntherapy, nas nevidenced nby nstatements nsuch
nas n“I’m
upset nabout nhaving nto ntest nmy nblood nsugars.”
- ANSWER: nD
Formulation nof nnursing ndiagnoses nis nusually na nthree-step nprocess. n“Anxiety” nis
nmissing nthe
“related nto” nand n“as nevidenced nby” nportions nof ndefining ncharacteristics. n“Anxiety
nrelated nto nnew ndrug ntherapy” nis nmissing nthe n“as nevidenced nby” nportion nof ndefining
ncharacteristics. nThe nstatementbeginning n“Anxiety nrelated nto nanxious nfeelings” nis
nincorrect nbecause nthe n“related nto” nsection nis nsimply na nrestatement nof nthe nproblem
n“anxiety,” nnot na nseparate nfactor nrelated nto nthe nresponse.
DIF: nCOGNITIVE nLEVEL: nUnderstanding
(Comprehension)TOP: nNURSING n PROCESS:
Nursing nDiagnosis
MSC: nNCLEX: nSafe nand nEffective nCare nEnvironment: nManagement nof nCare
, 3 n| nP n a n g n e
2. The npatient nis nto nreceive noral nguaifenesin n(Mucinex) ntwice na nday. nToday,
nthe nnurse nwas nbusy nandgave nthe nmedication n2 nhours nafter nthe nscheduled ndose
nwas ndue. nWhat ntype nof nproblem ndoes nthis nrepresent?
a. “Right ntime”
b. “Right ndose”
c. “Right nroute”
d. “Right
medication”
n
- nANSWER: nA
“Right ntime” nis ncorrect nbecause nthe nmedication nwas ngiven nmore nthan n30 nminutes
nafter nthe nscheduled ndose nwas ndue. n“Dose” nis nincorrect nbecause nthe ndose nis nnot
nrelated nto nthe ntime nthe
medication nadministration nis nscheduled. n“Route” nis nincorrect nbecause nthe nroute nis
nnot naffected.“Medication” nis nincorrect nbecause nthe nmedication nordered nwill nnot
nchange.
DIF: nCOGNITIVE nLEVEL: nApplying
(Application)TOP: nNURSING nPROCESS: nImplementation
MSC: nNCLEX: nSafe nand nEffective nCare nEnvironment: nSafety nand nInfection
nControl
3. The nnurse nhas nbeen nmonitoring nthe npatient’s nprogress non na nnew ndrug
nregimen nsince nthe nfirst ndoseand ndocumenting nthe npatient’s ntherapeutic nresponse
nto nthe
medication. nWhich nphase nof nthe nnursing nprocessed nthese nactions nillustrate?
a. Nursing ndiagnosis
PROCESS 9TH EDITION CHAPTER 1-58 BY
LINDA LANE LILLEY, SHELLY
RAINFORTH COLLINS, JULIE S. SNYDER||
LATEST 2025 WITH VERIFIED
SOLUTIONS|| ASSURED PASS!!!
,1|P a g e
PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
CHAPTER 1-58 BY LINDA LANE LILLEY, SHELLY RAINFORTH COLLINS,
JULIE S. SNYDER|| LATEST 2025 WITH VERIFIED SOLUTIONS|| ASSURED
PASS!!!
Chapter n01: nThe nNursing nProcess nand nDrug nTherapy
n MULTIPLE nCHOICE
1. During nan nintravenous n(IV) ninfusion nof namphotericin nB, na npatient
ndevelops ntingling nand nnumbnessin nhis ntoes nand nfingers. nWhat nwill nthe nnurse
ndo nfirst?
a. Discontinue nthe ninfusion nimmediately.
b. Reduce nthe ninfusion nrate ngradually nuntil nthe nadverse neffects nsubside.
c. Administer nthe nmedication nby nrapid nIV ninfusion nto nreduce nthese neffects.
d. Nothing; nthese nare nexpected nside neffects nof nthis nmedication.
- ANSWER: nA
Once nthe nintravenous ninfusion nof namphotericin nB nhas nbegun, nvital nsigns nmust nbe
nmonitored nfrequently nto nassess nfor nadverse nreactions nsuch nas ncardiac
ndysrhythmias, nvisual ndisturbances, nparesthesias n(numbness nor ntingling nof nthe
nhands nor nfeet), nrespiratory ndifficulty, npain, nfever, nchills,and nnausea. nIf nthese
nadverse neffects nor na nsevere nreaction noccur, nthe ninfusion nmust nbe
ndiscontinued(while nthe npatient nis nclosely nmonitored) nand nthe nprescriber
ncontacted. nThe nother noptions nare nincorrect.
DIF: nCOGNITIVE nLEVEL: nApplying
(Application)TOP: nNURSING nPROCESS: nImplementation
MSC: nNCLEX: nPhysiological nIntegrity: nPharmacological nand nParenteral nTherapies
,2 n| nP n a n g n e
The nnurse nis nwriting na nnursing ndiagnosis nfor na nplan nof ncare nfor na npatient nwho
nhas nbeen nnewlydiagnosed nwith ntype n2 ndiabetes. nWhich nstatement nreflects nthe
ncorrect nformat nfor na nnursing ndiagnosis?
a. Anxiety
b. Anxiety nrelated nto nnew ndrug ntherapy
c. Anxiety nrelated nto nanxious nfeelings nabout ndrug ntherapy, nas nevidenced
nby nstatements
such nas n“I’m nupset nabout nhaving nto ntest nmy nblood nsugars.”
d. Anxiety nrelated nto nnew ndrug ntherapy, nas nevidenced nby nstatements nsuch
nas n“I’m
upset nabout nhaving nto ntest nmy nblood nsugars.”
- ANSWER: nD
Formulation nof nnursing ndiagnoses nis nusually na nthree-step nprocess. n“Anxiety” nis
nmissing nthe
“related nto” nand n“as nevidenced nby” nportions nof ndefining ncharacteristics. n“Anxiety
nrelated nto nnew ndrug ntherapy” nis nmissing nthe n“as nevidenced nby” nportion nof ndefining
ncharacteristics. nThe nstatementbeginning n“Anxiety nrelated nto nanxious nfeelings” nis
nincorrect nbecause nthe n“related nto” nsection nis nsimply na nrestatement nof nthe nproblem
n“anxiety,” nnot na nseparate nfactor nrelated nto nthe nresponse.
DIF: nCOGNITIVE nLEVEL: nUnderstanding
(Comprehension)TOP: nNURSING n PROCESS:
Nursing nDiagnosis
MSC: nNCLEX: nSafe nand nEffective nCare nEnvironment: nManagement nof nCare
, 3 n| nP n a n g n e
2. The npatient nis nto nreceive noral nguaifenesin n(Mucinex) ntwice na nday. nToday,
nthe nnurse nwas nbusy nandgave nthe nmedication n2 nhours nafter nthe nscheduled ndose
nwas ndue. nWhat ntype nof nproblem ndoes nthis nrepresent?
a. “Right ntime”
b. “Right ndose”
c. “Right nroute”
d. “Right
medication”
n
- nANSWER: nA
“Right ntime” nis ncorrect nbecause nthe nmedication nwas ngiven nmore nthan n30 nminutes
nafter nthe nscheduled ndose nwas ndue. n“Dose” nis nincorrect nbecause nthe ndose nis nnot
nrelated nto nthe ntime nthe
medication nadministration nis nscheduled. n“Route” nis nincorrect nbecause nthe nroute nis
nnot naffected.“Medication” nis nincorrect nbecause nthe nmedication nordered nwill nnot
nchange.
DIF: nCOGNITIVE nLEVEL: nApplying
(Application)TOP: nNURSING nPROCESS: nImplementation
MSC: nNCLEX: nSafe nand nEffective nCare nEnvironment: nSafety nand nInfection
nControl
3. The nnurse nhas nbeen nmonitoring nthe npatient’s nprogress non na nnew ndrug
nregimen nsince nthe nfirst ndoseand ndocumenting nthe npatient’s ntherapeutic nresponse
nto nthe
medication. nWhich nphase nof nthe nnursing nprocessed nthese nactions nillustrate?
a. Nursing ndiagnosis
